March 29, 2018
On March 29th, 2018 Anneke Sijbers received Enzyre’s award of € 10,000 during a MedtechPartners meeting celebrating their 10-year anniversary.
Written by
Founder & CFO
Share this article
Enzyre is now preparing to raise an investment round. The proceeds will be used to (a) finalize the development of the ENZYPAD en ENZYCARD Hemophilia A, (b) manufacture the portable instrument & disposable, and (c) perform studies to obtain regulatory approval in EU & US. The product will be commercialized worldwide with support of our pharma partner. Interested candidate investors are encouraged to contact us at investors@enzyre.com.
Get involved
Enzyre BV
Transistorweg 5
6534-AT Nijmegen
The Netherlands
